EUVIMEDEUVIMED entdecken
EditorialOpen Access

The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters

Arya Babul, Parisa Mahdavi

Cureus · 31.10.2026

DOI: 10.7759/cureus.118912 ↗

Kurz gefasst

Editorial in der Zeitschrift Cureus, erschienen am 31.10.2026. Verfasst von Arya Babul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences, West Career and Technical Academy, Las Vegas, USA. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adolescentsbuprenorphinecascade of careepistemic injusticefentanyl eramedication accessopioid use disorderpediatric labelingregulatory barrierstreatment disparities

Autor:innen und Institutionen

  • Biomedical Sciences, West Career and Technical Academy, Las Vegas, USA.
  • Biomedical Sciences, Society for Awareness of Neglected Diseases, Las Vegas, USA.
  • Drug Regulatory Affairs, Tavolar LLC, Las Vegas, USA.

Zitieren

APA

Babul, A., & Mahdavi, P. (2026). The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters. Cureus. https://doi.org/10.7759/cureus.118912

Vancouver

Babul A, Mahdavi P. The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters. Cureus. 2026. doi:10.7759/cureus.118912

BibTeX
@article{Babul2026,
  author = {Babul, Arya and Mahdavi, Parisa},
  title = {The Adolescent Indication for Buprenorphine: What It Is, What It Is Not, and Why It Matters},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.118912}
}
Kostenlos starten →